These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 869901)

  • 41. Hepatocyte gene therapy in a large animal: a neonatal bovine model of citrullinemia.
    Lee B; Dennis JA; Healy PJ; Mull B; Pastore L; Yu H; Aguilar-Cordova E; O'Brien W; Reeds P; Beaudet AL
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3981-6. PubMed ID: 10097149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of the mechanism of the argininosuccinate synthetase reaction by static and dynamic quench experiments.
    Ghose C; Raushel FM
    Biochemistry; 1985 Oct; 24(21):5894-8. PubMed ID: 3878725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mild citrullinemia in Caucasians is an allelic variant of argininosuccinate synthetase deficiency (citrullinemia type 1).
    Häberle J; Pauli S; Schmidt E; Schulze-Eilfing B; Berning C; Koch HG
    Mol Genet Metab; 2003 Nov; 80(3):302-6. PubMed ID: 14680976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pregnancy in a healthy woman with untreated citrullinemia.
    Potter MA; Zeesman S; Brennan B; Kobayashi K; Gao HZ; Tabata A; Saheki T; Whelan DT
    Am J Med Genet A; 2004 Aug; 129A(1):77-82. PubMed ID: 15266621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular basis of enzyme abnormalities in urea cycle disorders. With special reference to citrullinemia and argininosuccinic aciduria.
    Saheki T; Kobayashi K; Ichiki H; Matuo S; Tatsuno M; Imamura Y; Inoue I; Noda T; Hagihara S
    Enzyme; 1987; 38(1-4):227-32. PubMed ID: 3440446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of glucagon on urinary excretion of urea and on plasma ammonia level in argininosuccinate synthetase deficiency.
    Tamura S; Kawata S; Fukuda K; Inui Y; Kakimoto H; Ishiguro H; Namba M; Kono N; Matsuzawa Y
    J Gastroenterol; 1994 Feb; 29(1):31-4. PubMed ID: 8199693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Argininosuccinate synthetase: essential role of cysteine and arginine residues in relation to structure and mechanism of ATP activation.
    Kumar S; Lennane J; Ratner S
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):6745-9. PubMed ID: 3863125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Level of translatable messenger RNA coding for argininosuccinate synthetase in the liver of the patients with quantitative-type citrullinemia.
    Sase M; Kobayashi K; Imamura Y; Saheki T; Nakano K; Miura S; Mori M
    Hum Genet; 1985; 69(2):130-4. PubMed ID: 3972414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Citrullinemic lymphocytes in long term culture.
    Spector EB; Bloom AD
    Pediatr Res; 1973 Aug; 7(8):700-5. PubMed ID: 4732110
    [No Abstract]   [Full Text] [Related]  

  • 50. Pancreatic secretory trypsin inhibitor gene is highly expressed in the liver of adult-onset type II citrullinemia.
    Kobayashi K; Nakata M; Terazono H; Shinsato T; Saheki T
    FEBS Lett; 1995 Sep; 372(1):69-73. PubMed ID: 7556646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case of citrullinemia with abnormal messenger RNA for argininosuccinate synthetase.
    Nukada O; Uchiyama C; Ubuka S; Yoda T; Kobayashi K; Ichiki H; Saheki T
    Acta Paediatr Jpn; 1991 Oct; 33(5):672-7. PubMed ID: 1799125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substrate induced conformational changes in argininosuccinate synthetase.
    Lemke CT; Howell PL
    J Biol Chem; 2002 Apr; 277(15):13074-81. PubMed ID: 11809762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. L-citrulline recycling by argininosuccinate synthetase and lyase in rat gastric fundus.
    Van Geldre LA; Timmermans JP; Lefebvre RA
    Eur J Pharmacol; 2002 Nov; 455(2-3):149-60. PubMed ID: 12445581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic cooperation between argininosuccinate synthetase and argininosuccinate lyase deficient human fibroblasts.
    Davidson JS; Baumgarten IM; Harley EH
    Exp Cell Res; 1984 Feb; 150(2):367-78. PubMed ID: 6692857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Enzymatic analysis of citrullinemia in Japan].
    Saheki T
    Seikagaku; 1982; 54(7):435-43. PubMed ID: 6754830
    [No Abstract]   [Full Text] [Related]  

  • 56. Improved standards for prenatal diagnosis of citrullinemia.
    Miller MJ; Soler-Alfonso CR; Grund JE; Fang P; Sun Q; Elsea SH; Sutton VR
    Mol Genet Metab; 2014 Jul; 112(3):205-9. PubMed ID: 24889030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determination of enzyme activity by chromatography and videodensitometry. II. Urea cycle enzymes in tissue homogenates.
    Karsai T; Ménes A; Molnár J; Elödi P
    Acta Biochim Biophys Acad Sci Hung; 1979; 14(3):133-42. PubMed ID: 232808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolite regulation of argininosuccinate synthetase in cultured human cells.
    Jackson MJ; Allen SJ; Beaudet AL; O'Brien WE
    J Biol Chem; 1988 Nov; 263(31):16388-94. PubMed ID: 3182797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations in argininosuccinate synthetase mRNA in Japanese patients, causing classical citrullinemia.
    Kobayashi K; Shaheen N; Terazono H; Saheki T
    Am J Hum Genet; 1995 Jan; 56(1):356. PubMed ID: 7825601
    [No Abstract]   [Full Text] [Related]  

  • 60. Moderate citrullinaemia without hyperammonaemia in a child with mutated and deficient argininosuccinate synthetase.
    Ruitenbeek W; Kobayashi K; Iijima M; Smeitink JA; Engelke UF; De Abreu RA; Kwast HT; Saheki T; Boelen CA; De Jong JG; Wevers RA
    Ann Clin Biochem; 2003 Jan; 40(Pt 1):102-7. PubMed ID: 12542919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.